OUR TEAM
LEADERSHIP
Anand Shukla
CEO & Co-Founder
- Former VP, R&D and Clinical Operations at Nivagen Pharmaceuticals
- Leadership roles at Sandoz (Novartis), FibroGen, and Teva
- Scaled Nivagen from early stage to $90M+ revenue, expanding portfolio from 0 to 165+ products
- Successfully raised $100M+ in equity and debt financing
- Led development of a 100,000 sq. ft. sterile manufacturing facility and conversion to FDA-approved GMP operations
Brings proven ability to build, scale, and commercialize pharmaceutical programs end-to-end
Dr. Sreejayan (Sree) Nair
CSO & Co-Founder
Distinguished pharmacologist and translational scientist whose work forms the scientific foundation of WiTii’s platform.
- Chair, Division of Pharmaceutical Sciences and Professor of Pharmacology, University of Wyoming
- Director, Biomedical Sciences Graduate Program and Mentoring Director, Wyoming Sensory Biology Center
- Inventor of Cathepsin K method-of-use patents underlying WiT‑001
- 100+ peer-reviewed publications and editor of multiple academic books used in global curricula
- Recognized leader in wound healing and protease biology research
Originator of WiTii’s first-in-class mechanism and core IP
TEAM MEMBERS
Dr. Shivani Undrala, Ph.D. RAC
Regulatory & CMC Strategy Consultant
- Former Regulatory Affairs Manager at Amgen, supporting global filings and lifecycle strategy
- Leadership and R&D experience at Insys Therapeutics, spanning formulation, CMC, and regulatory development
- Expertise in 505(b)(2) pathway, IND/NDA submissions, and FDA interactions
- Experience across formulation, clinical development, and CMC strategy
Drives regulatory pathway, development strategy, and clinical readiness
Dr. Mitchell Helling
Analytical & CMC Consultant
Analytical scientist supporting pharmaceutical quality, method development, and translational scalability.
- Experience at MilliporeSigma in pharmaceutical quality control and analytical testing
- Expertise in LC-MS, GC-MS, HPLC/UPLC, and analytical method validation
- Background in metabolomics and complex analytical system development
Enables robust analytical development and CMC readiness for WiT‑001
AARON ALCOTT
Consultant
- Oversees day-to-day experimental workflows and lab operations
- Supports timely execution and coordination of research activities
- Brings strong problem-solving ability in dynamic, real-time environments
Ensures that research programs remain on track, focused, and execution-ready
Dr. Garima Sharma
Project Manager & IT Lead
- Expertise in website development, SEO, branding, and content strategy
- Background in applied psychology and customer behavior insights
- Experience managing multi-industry projects and cross-functional teams globally
Brings a structured, research-driven approach to building digital presence and ensuring execution consistency
Supported by a network of consultants in CMC, toxicology, medical writing, grant writing, regulatory, PV, compliance, and statistics.
SCIENTIFIC ADVISORY BOARD
Dr. Robert Kirsner
MD PhD
Chairman, Wound Healing Society
University of Miami, 30+ years in clinical research
Dr.Arlen Meyers
MD MBA
President & CEO, Society of Physician
Entrepreneur, University of Colorado, School of Medicine
Dr.Narendra Trivedi MD
Innovation Champion at Kaiser Permanente
President Emeritus California Society of Anesthesiologists
ADVISORY BOARD
Jay Shukla
CEO Nivagen Pharma
20+ years retail/Dept. of health, Albertson’s
Bud Michael
MD, Renaissance Management Services
5X Turnaround CEO, 20+ years leading teams,
Priyesh Sanghvi
Co-Founder & CEO Visionify.ai